scholarly journals Case Report: Interatrial Thrombus in Left Atrial Septal Pouch Prohibiting Transseptal Puncture for Percutaneous Mitral Valve Therapy

CJC Open ◽  
2021 ◽  
Author(s):  
Muhammed Gerçek ◽  
Masathoshi. Hata ◽  
Jan Gummert ◽  
Volker Rudolph ◽  
Kai Peter Friedrichs
2020 ◽  
Vol 23 (6) ◽  
pp. E743-E745
Author(s):  
Xuejun Sun ◽  
Dandan Hong ◽  
Haibo Liu ◽  
Hongmu Li

Acute mitral valve injury following percutaneous left atrial appendage (LAA) occlusion is a rare, but potentially life-threatening complication. This report presents a case of severe mitral valve injury following left atrial appendage occlusion (LAAO) that required mitral valve replacement. The LAAO device successfully was removed, and the LAA was closed with a double-running polypropylene suture. In addition, the mitral valve was replaced with an artificial valve. The patient had an uneventful clinical evolution and was discharged 10 days after emergency surgery.


2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Atsushi Morishita ◽  
Seiichiro Katahira ◽  
Takeshi Hoshino ◽  
Kazuhiko Hanzawa ◽  
Hideyuki Tomioka

2020 ◽  
Vol 4 (5) ◽  
pp. 1-4
Author(s):  
Cornelia Biller ◽  
Karlo Filipovic ◽  
Jakob Lüker ◽  
Daniel Steven

Abstract Background Atrial flow regulator (AFR) (Occlutech, Helsingborg, Sweden) are self-expanding, circular devices. A flexible waist in the centre connects the two discs and has a centrally located shunt. Case summary We report a case of an 80-year-old woman undergoing a repeat left atrial ablation for persistent atrial fibrillation with an implanted AFR. The AFR was implanted 1 year prior to the procedure for heart failure with preserved ejection fraction as part of the AFR-PRELIEVE trial. A single, fluoroscopy-guided, transseptal puncture was performed infero-posterior to the device, allowing the positioning of the mapping (LASSO® 20 mm, Biosense Webster, Irvine, CA, USA) and ablation (Thermocool Smarttouch SF, CARTO®, Biosense Webster, Irvine, CA, USA) catheter in the left atrium. Three-dimensional mapping (CARTO®, Biosense Webster, Irvine, CA, USA) and left atrial ablation were successfully performed. After the procedure, fluoroscopy and transthoracic echocardiography showed an unchanged device position. Discussion To our knowledge, this is the first case report of a transseptal puncture in a patient with an implanted AFR. Transseptal puncture in patients with an implanted AFR seems to be safe and feasible. With device diameters of 21–23 mm and based on previous studies on similar devices, transseptal puncture should be possible in most patients, as opposed to puncture through the device.


2018 ◽  
Vol 2 (3) ◽  
pp. 160-163
Author(s):  
Rameshwar Roopchandar ◽  
Meenakshi Kadiyala ◽  
Nithyananthan Peramanathan ◽  
Mahendra Kumar Kalappan ◽  
Kannan Rajendran ◽  
...  
Keyword(s):  

Author(s):  
Hironobu Nishiori ◽  
Hiroyuki Watanabe ◽  
Yuichi Hirano ◽  
Masayoshi Otsu

We report a case of a 63-year-old man without a history of atrial fibrillation or mitral valve disease who was admitted to our hospital. Echocardiography revealed a large left atrial mass attached to the atrial septum. We suspected the mass to be a myxoma, but it turned out to be a large thrombus after the surgery. Left atrial thrombus without mitral valve disease or atrial fibrillation is rare. Although the degree of urgency varies based on the case, early surgical resection is recommended for a large left atrial thrombus to prevent embolism.


Author(s):  
Beatriz Bodanese ◽  
Ana Borba ◽  
Valdir Lippi Júnior ◽  
Kátia Purim

This report describes a therapeutic alternative for correction of severe mitral stenosis causing high-response atrial fibrillation, and consequent syncope in a woman at 8 weeks gestational age. A percutaneous valvuloplasty attempt failed, because the transseptal puncture was not possible, and a definitive resolution was achieved by transapical valvuloplasty, via left thoracotomy through an inframammary incision, with direct access to the mitral valve. Since this was an original and complex procedure, this case is of relevant importance in the treatment of severe mitral stenosis in patients whose conditions render a conventional procedure impossible.


Sign in / Sign up

Export Citation Format

Share Document